Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: Comparison between 3.0T and 1.5T MR systems

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 3, 2009, Pages 595-600

  Kim, Tonsok ^a,c   Murakami, Takamichi ^b   Hori, Masatoshi ^a   Onishi, Hiromitsu ^a   Tomoda, Kaname ^a   Nakamura, Hironobu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Liver neoplasms; Metastatic liver tumor; MR imaging; SPIO (ferucarbotran); Ultrahigh magnetic field

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHO PLANAR IMAGING; FEMALE; HUMAN; IMAGE QUALITY; LIVER TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COLONIC NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MALE; MIDDLE AGED; OXIDES;

EID: 63449095958     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21384     Document Type: Article

References (27)

1. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200:785-792.
2. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 1990; 155:763-770.
3. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995;196:471-478.
4. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson P. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alter-native-free response receiver operating characteristic analysis. Ra-diology1999;210:459-466.
5. Muller RD, Vogel K, Neumann K, et al. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver.Acta Radiol 1999;40:628-635.
6. Bluemke DA, Paulson EK, Choti MA, et al. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-en-hanced MR imaging and dual-phase helical CT. AJR Am J Roent-genol 2000;175:1653-1658.
7. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superpara-magnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158.
8. Hori M, Murakami T, Kim T, et al. Detection of hypervascular hepatocellular carcinoma: comparison of SPIO-enhanced MRI with dynamic helical CT. J Comput Assist Tomogr 2002;26:701-710.
9. Kang BK, Lim JH, Kim SH, et al. Preoperative depiction of hepato- cellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 2003;226:79-85.
10. Ward J, Guthrie JA, D Wilson, et al. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging-comparison of optimized sequences. Radiology 2003;228:709-718.
11. de Bazelaire CMJ, GD Duhamel, Rofsky NM, MD Alsop DC. MR imaging relaxation times ofabdominal and pelvic tissues measured in vivo at 3.0T: preliminary results. Radiology 2004;230:652-659.
12. Merkle EM, Haugan PA, Thomas J Jaffe TA, Gullotto C. 3.0- versus 1.5T MR cholangiography: a pilot study. AJR Am J Roentgenol 2006;186:516-521.
13. Chang JM, Lee JM, Lee MW, et al. Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5T and 3.0T imaging for detection of focal malignant liver lesions. Invest Radiol 2006;41:168-174.
14. O'Regan DP, Fitzgerald J, Allsop J, et al. A comparison of MR cholan-giopancreatography at 1.5 and 3.0T. Br J Radiol 2005;78:894-898.
15. Kramer U, Nael K, Laub G, et al. High-resolution magnetic resonance angiography of the renal arteries using parallel imaging acquisition techniques at 3.0T: initial experience. Invest Radiol 2006;41:125-132.
16. Edelman RR, Salanitri G, Brand R, et al. Magnetic resonance imaging of the pancreas at 3.0 Tesla: qualitative and quantitative comparison with 1.5 Tesla. Invest Radiol 2006;41:175-180.
17. Merkle EM, Dale BM. Abdominal MRI at 3.0T: the basics revisited. AJR Am J Roentgenol 2006;186:1524-1532.
18. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivityencoding for fast MRI. Magn Reson Med 1999;42:952-962.
19. Kuhl, CK, Gieseke J, von Falkenhausen M, et al. Sensitivity encoding for diffusion-weighted MR imaging at 3.0T: intraindividual comparative study. Radiology2005;234:517-526.
20. Nael K, Saleh R, Lee M, et al. High-spatial-resolution contrast-enhanced MR angiography of abdominal arteries with parallel acquisition at 3.0T: initial experience in 32 patients. AJR Am J Roentgenol 2006;187:W77-W86.
21. Martin DR, Friel HT, Danrad R, De Becker J, Hussain SM. Approach to abdominal imaging at 1.5 Tesla and optimization at 3 Tesla. Magn Reson Imaging Clin N Am 2005;13:241-254.
22. Ra JB, Rim CY. Fast imaging using subencoding data sets from multiple detectors. Magn Reson Med 1993;30:142-145.
23. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
24. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxide-enhancedT1- weightedMRimaging. Radiology1997;203:449-456.
25. Ward J, Chen F, Guthrie JA, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000;214:159-166.
26. Matsuo M, Kanematsu M, Itoh K, et al. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs. AJR Am J Roentgenol 2004;182:235-242.
27. Kim MJ, Kim JH, Choi JY, et al. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-W266.